9 December 2020 - Pfizer has cleared the next hurdle in the race to get its COVID-19 vaccine approved for emergency use in the US after the FDA released documents that raised no new issues about its safety or efficacy.

Pfizer and German partner BioNTech submitted data to the FDA last month about their coronavirus vaccine based on data showing the two dose regimen was 95 per cent effective against COVID-19 and had no major safety issues.

Read Sydney Morning Herald article